The PVT-1 oncogene is a myc protein target is overexpressed in transformed cells

被引:129
作者
Carramusa, Letizia
Contino, Flavia
Ferro, Arianna
Minafra, Luigi
Perconti, Giovanni
Giallongo, Agata
Feo, Salvatore
机构
[1] Univ Palermo, Dip Oncol Sperimentale & Applicaz Clin, I-90146 Palermo, Italy
[2] Dipartimento Oncol La Maddalena, Palermo, Italy
[3] CNR, Ist Biomed & Immunol Mol, Palermo, Italy
关键词
D O I
10.1002/jcp.21133
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The human PVT-I gene is located on chromosome 8 telomeric to the c-Myc gene and it is frequently involved in the translocations occurring in variant Burkitt's lymphomas and murine plasmacytomas. It has been proposed that PVT-I regulates c-Myc gene transcription over a long distance. To get new insights into the functional relationships between the two genes, we have investigated PVT-I and c-Myc expression in normal human tissues and in transformed cells. Our findings indicate that PVT-I expression is restricted to a relative low number of normal tissues compared to the wide distribution of c-Myc mRNA, whereas the gene is highly expressed in many transformed cell types including neuroblastoma cells that do not express c-Myc. Reporter gene assays were used to dissect the PVT- I promoter and to identify the region responsible for the elevated expression observed in transformed cells. This region contains two putative binding sites for Myc proteins. The results of transfection experiments in RAT1-MycER cells and chromatin immunoprecipitation (ChlP) assays in proliferating and differentiated neuroblastoma cells indicate that PVT- I is a downstream target of Myc proteins.
引用
收藏
页码:511 / 518
页数:8
相关论文
共 27 条
  • [1] BAKKUS MHC, 1990, ONCOGENE, V5, P1359
  • [2] Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: Applications in pharmacogenomic gene expression studies
    Blanquicett, C
    Johnson, MR
    Heslin, M
    Diasio, RB
    [J]. ANALYTICAL BIOCHEMISTRY, 2002, 303 (02) : 209 - 214
  • [3] THE HUMAN T-CELL RECEPTOR GENES ARE TARGETS FOR CHROMOSOMAL-ABNORMALITIES IN T-CELL TUMORS
    BOEHM, T
    RABBITTS, TH
    [J]. FASEB JOURNAL, 1989, 3 (12) : 2344 - 2359
  • [4] Chemically modified tetracyclines induce cytotoxic effects against J774 tumour cell line by activating the apoptotic pathway
    D'Agostino, P
    Ferlazzo, V
    Milano, S
    La Rosa, M
    Di Bella, G
    Caruso, R
    Barbera, C
    Grimaudo, S
    Tolomeo, M
    Feo, S
    Cillari, E
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (01) : 63 - 73
  • [5] FEO S, 1995, MOL CELL BIOL, V15, P5991
  • [6] Feo S, 1996, ONCOGENE, V13, P1521
  • [7] FEO S, 1994, ONCOGENE, V9, P955
  • [8] ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor:: relationship with Myc promoter-binding protein 1 (MBP-1)
    Feo, S
    Arcuri, D
    Piddini, E
    Passantino, R
    Giallongo, A
    [J]. FEBS LETTERS, 2000, 473 (01): : 47 - 52
  • [9] Genomic targets of the human c-Myc protein
    Fernandez, PC
    Frank, SR
    Wang, LQ
    Schroeder, M
    Liu, SX
    Greene, J
    Cocito, A
    Amati, B
    [J]. GENES & DEVELOPMENT, 2003, 17 (09) : 1115 - 1129
  • [10] Annexin A2 is a novel RNA-binding protein
    Filipenko, NR
    MacLeod, TJ
    Yoon, CS
    Waisman, DM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) : 8723 - 8731